TechnologiesTechnologiesTechnologiesTechnologies
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Technologies

  • Home
  • Technologies

Innovita Research has developed some experimental technologies that can be provided for scientific and other customers. In many cases we can help with the preparation and application of these technologies under customer local governmental rules/requirements.

  • Cancer immunotherapy
  • T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders
  • Adoptive cell-based immunotherapy for chronic inflammatory diseases
  • OPI therapy for motor and skin diseases
  • Storage of immune cells

Related science news

  • Why our cells almost never fail
    July 25, 2026
  • AI platform flips the script on how tumors are analyzed
    July 24, 2026
  • AI Tool Improves Prediction of Who Will Respond to Cancer Immunotherapy Drugs
    July 23, 2026
  • A quantum mechanics approach to artificial intelligence can improve cancer outcomes
    July 23, 2026
  • Stem Cell scientists engineer “synthetic organizer” cells to improve kidney organoids
    July 13, 2026
More news.
© 2017 - 2026 Innovita Research | Privacy policy